Daniel Przybysz

Dr. Daniel Przybysz (born March 25, 1988) is a Brazilian Radiation-Oncologist. His practice is mainly focused on lung cancer treatment and high technology approaches toward better patient care.

Daniel Przybysz, MD 2017[1]

Przybysz has a medical degree from the Federal University of Parana, Brazil jointly with Harvard Medical School. He graduated in 2013 with high-honors after doing his internships in Oncology-related rotations.

After spending some time at the Massachusetts General Hospital in Boston and at the University of Texas MD Anderson Cancer Center, Przybysz began a Radiation-Oncology program at the Brazilian National Cancer Institute. He graduated residency and was invited to start a position as Visitor Researcher in Radiation-Oncology at the Washington University in St. Louis.

Przybysz also works as an Oncology Reviewer for UpToDate and as an author, editor and reviewer for lung-related articles at the International Journal of Radiation Oncology, Biology and Physics, contributing on high-level reviews for medical content.

Publications

Przybysz's interest in clinical cancer research and outcomes has culminated in several publications, some of listed below:

  • Henke, Lauren E.; Kashani, Rojano; Przybysz, Daniel; Hilliard, Jessica; Curcuru, Austen; Green, Olga L.; Bradley, Jeffrey D.; Robinson, Clifford G. (2017-06-01). "(S009) In Silico Trial of MR-Guided Mid-Treatment Adaptive Planning for Hypofractionated Stereotactic Radiotherapy in Centrally Located Thoracic Tumors". International Journal of Radiation Oncology*Biology*Physics. 98 (2): E3. doi:10.1016/j.ijrobp.2017.02.045. ISSN 0360-3016.[2]
  • "Wednesday 31 May / ISRS - INTERNATIONAL STEREOTACTIC RADIOSURGERY SOCIETY". www.isrscongress.org. Retrieved 2017-08-07.[3]
  • Przybysz, Daniel; Bradley, Jeffrey D. (2017-06-01). "Challenging Situations for Lung SBRT". Journal of Thoracic Oncology. 12 (6): 916–918. doi:10.1016/j.jtho.2017.04.007. ISSN 1556-0864. PMID 28532561.[4]
  • Magnetic Resonance Image-Guided Radiation Therapy (MR-IGRT) for the Treatment of Prostate Cancer: Initial Patient Selection and Clinical Experience - Journal of Urology 2017[5]
  • Lung SBRT using MRI-guided radiation therapy: possible GTV changes and benefits of adaptive therapy In Silico Trial of MR-Guided Mid-Treatment Adaptive Planning for Hypofractionated Stereotactic Radiotherapy in Centrally Located Thoracic Tumors - IJROBP 2016[6]
  • Lung SBRT using MRI-guided radiation therapy: possible GTV changes and benefits of adaptive therapy - SBRT 2016[7]
  • Henke, L.; Przybysz, D.; Kashani, R.; Green, O.; Robinson, C.; Bradley, J. (April 2016). "EP-1225: MRI-defined GTV change during SBRT for unresectable or oligometastatic disease of the central thorax". Radiotherapy and Oncology. 119: S580–S581. doi:10.1016/S0167-8140(16)32475-6.[8]
  • A comparison between VMAT, IMRT and GAP techniques on the Medulloblastoma approach: different technologies aiming better patient care - Radiology 2015[9]
  • Potential benefits of Neoadjuvant Radiation Therapy On Overall Survival in Advanced Breast Cancer Patients - Radiology 2016[10]
  • Przybysz, D.; Hill, E. K.; Dizon, D. S. (2015-11-01). "Sexual Dysfunction After Cancer: Findings From the Program in Women's Oncology Center for Sexuality, Intimacy, and Fertility". International Journal of Radiation Oncology*Biology*Physics. 93 (3): E487. doi:10.1016/j.ijrobp.2015.07.1790. ISSN 0360-3016.[11]
  • Vieiralves, Yasmine; Przybysz, Daniel; et al. (31 May 2017). Visual outcomes predictors after stereotactic radiosurgery for choroidal melanomas. ISRS2017: International Stereotactic Radiosurgery Society. Retrieved 2017-08-07.[12]

Nevertheless, Przybysz is now developing projects using high-technology treatment planning towards better patient care. At present, he is engaged in several studies regarding lung cancer, CNS malignancies and prostate cancer.[13]

He has been recognized and awarded as a Leading Physician of The World by the International Association of Healthcare Providers in 2017.[14]

References
  1. "LinkedIn Profile".
  2. "IJROBP 2017". doi:10.1016/j.ijrobp.2017.02.045. Cite journal requires |journal= (help)
  3. "ISRS 2017".
  4. "JTO".
  5. Fischer-Valuck, B. W.; Rao, Y. J.; Rudra, S.; Przybysz, D.; Germino, E.; Samson, P.; Baumann, B. C.; Gay, H.; Michalski, J. (2018). "Journal of Urology". 199 (2): 416–423. doi:10.1016/j.juro.2017.08.086. PMID 28842247. Cite journal requires |journal= (help)
  6. "Red Journal".
  7. "SBRT 2016".
  8. "Green Journal".
  9. "RSNA 2015".
  10. "RSNA 2015".
  11. "IJROBP 2015".
  12. "ISRS 2017".
  13. Przybysz, Daniel (7 August 2017). "LinkedIn Profile". LinkedInc.
  14. "IAHCP Website".
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.